Pay in 4 interest-free payments of $10.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Dacinostat impairs short-term engraftment potential of leukemic stem cells
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
Dogs receiving capromorelin (30 mg/mL) have food consumption that is significantly greater than dogs treated with placebo
TRPM8 antagonist 2 (0
Vemurafenib (PLX4032
SB-334867 (base) - an orexin antagonist. CAS# 792173-99-0 Catalog No.:M7114-10 Dacinostat impairs short-term engraftment potentialSB 334867, an orexin antagonist, CAS No. 792173 99 0, is an orexin antagonist. SB 334867 was the first non peptide antagonist developed that is selective for the orexin receptor subtype OX1, with around 50x selectivity for OX1 over OX2 receptors. It has been shown to produce sedative and anorectic effects in animals, and has been useful in characterising the orexinergic regulation of brain systems involved with appetite and sleep, as well as other
US$ 12.00
US$ 82.00
US$ 21.00
US$ 189.00
US$ 198.00
US$ 129.00
US$ 28.00